David Lomb

David Lomb currently serves as Vice President and Director of Consulting Operations at Lumanity, a position held since March 2022. Previously, Lomb held roles such as Principal and Director of Consulting Operations at Cello Health BioConsulting (formerly Defined Health) from March 2010 to March 2022, where responsibilities included conducting commercial assessments and primary research with clinicians and key opinion leaders. Academic experience includes serving as a Fellow in the Early Technology Assessment Program at Harvard University and as a Postdoctoral Fellow in Pathology at Harvard Medical School, where research focused on the SIRT5 knockout mouse. Lomb began academic training as a Graduate Research Assistant at the University of Rochester, where significant findings were made related to HIF prolyl hydroxylases, and as a Research Assistant at the Research Institute on Addictions. Lomb earned a PhD in Pharmacology from the University of Rochester.